United States News Todas as matérias

Travel + Leisure (NYSE:TNL) reported second-quarter revenue of $1.06 billion, up 4%, with net income reaching $109 million.

Wabtec (NYSE:WAB) reported second-quarter sales of $3.18 billion, up 17.5%, with growth across its Freight and Transit segments.

PulteGroup (NYSE:PHM) reported second-quarter net income of $472 million, or $2.48 per share, on $3.8 billion in home sale revenue.

AT&T (NYSE:T) reported second-quarter revenue of $31.6 billion, up 2.3%, as fiber and wireless customer growth supported higher earnings.

Greenwich LifeSciences (NASDAQ:GLSI) received UK regulatory approval to add an estimated 5–10 sites to its Phase III FLAMINGO-01 breast cancer trial.

Otis Worldwide (NYSE:OTIS) reported second-quarter sales of $3.86 billion, up 7%, as Service growth offset weaker New Equipment profitability.

TE Connectivity (NYSE:TEL) reported record fiscal third-quarter sales of $5.16 billion, up 14% year over year and 12% organically.

Cal-Maine Foods (NASDAQ:CALM) reported $552.6 million in fourth-quarter sales and a $35.9 million loss, or $0.76 per share.

Repligen (NASDAQ:RGEN) agreed to acquire BioLife Solutions (NASDAQ:BLFS) in a cash-and-stock transaction valued at approximately $1.5 billion.

Joby Aviation (NYSE:JOBY) signed a multi-year agreement making Virgin Atlantic its exclusive UK airline partner for air taxi services.

EU regulators will formally outline subsidy concerns against JD.com (NASDAQ:JD) over its $2.5 billion bid for Ceconomy.

Alphabet (NASDAQ:GOOG) reported second-quarter revenue of $119.8 billion, up 24%, as Services and Cloud sales increased.

ServiceNow (NYSE:NOW) reported second-quarter subscription revenue of $3.88 billion, up 24.5%, as total revenue increased 24% to $3.99 billion.

Genenta (NASDAQ:GNTA) said Sòphia High Tech’s FY2025 sales rose 29.3% to €7.17 million, alongside increased operating profitability.

ADTRAN Holdings (NASDAQ:ADTN) reported preliminary second-quarter revenue of $280 million–$282 million, below its $283 million–$303 million guidance.

Data centre provider Iren (NASDAQ:IREN) has secured US$2.8 billion in new cloud service agreements.

KIDZ AI (NASDAQ:KIDZ) signed a 60-month, $44.6 million GPU compute agreement with Canopy Wave for enterprise AI inference workloads.

Gilead Sciences (NASDAQ:GILD) and Merck (NYSE:MRK) said their once-weekly HIV pill maintained suppression through Week 48 in two Phase 3 trials.

Charles Schwab (NYSE:SCHW) reported record Q2 net revenue of $7.07 billion, up 21%, while net income increased 32% to $2.8 billion.

Microsoft (NASDAQ:MSFT) agreed to spend billions on Mistral AI’s European infrastructure while expanding the French startup’s distribution through Azure.

Tempus AI (NASDAQ:TEM) agreed to acquire Personalis (NASDAQ:PSNL) for $1.5 billion, adding cancer-monitoring technology to its oncology platform.

Novo Nordisk (NYSE:NVO) sued Eli Lilly (NYSE:LLY) in New Jersey, challenging GLP-1 advertisements served more than 700 million times.

Bluejay Diagnostics (NASDAQ:BJDX) completed enrollment of 750 patients in its SYMON-II study evaluating 28-day sepsis mortality risk.

Forestar Group (NYSE:FOR) reported fiscal Q3 revenue of $407.0 million, up 4%, as residential lot sales increased 1% to 3,659.